Logo

Quoin Pharmaceuticals, Ltd.

QNRX

Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.ā€ā€ā€¦ read more

Healthcare

Biotechnology

7 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$7.36

Price

+2.37%

$0.17

Market Cap

$4.329m

Small

Price/Earnings

0x

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$100.370k

-

1y CAGR

-

3y CAGR

-

5y CAGR
Earnings

-$12.169m

-

1y CAGR

-

3y CAGR

-

5y CAGR
EPS

-$41.64

-

1y CAGR

-

3y CAGR

-

5y CAGR
Book Value

$2.551m

$8.913m

Assets

$6.361m

Liabilities

-

Debt
Debt to Assets

0.00%

-

Debt to EBITDA
Free Cash Flow

-$10.696m

-

1y CAGR

-

3y CAGR

-

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
Press Releases
Statements and updates from the company
↑ TopSummaryPriceFinancialsPress Releases